期刊
JOURNAL OF MATERIALS CHEMISTRY C
卷 7, 期 31, 页码 9448-9454出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c9tc01929d
关键词
-
资金
- National Natural Science Foundation of China [81773674, 81573383, 21763002]
- NSFHP [2017CFA024, 2017CFB711, 2016ACA126]
- Health Commission of Hubei Province Scientific Research Project [WJ2019M177, WJ2019M178]
- Tibet Autonomous Region Science and Technology Plan Project Key Project [XZ201901-GB-11]
- Shenzhen Science and Technology Research Grant [JCYJ20170303170809222]
- Fundamental Research Funds for the Central Universities
The integration of molecular imaging probes into a biodegradable, noncytotoxic and biocompatible nanoplatform is very promising for high efficacy tumor diagnosis but is still a great challenge. Herein, lactoferrin (Lf), an iron-binding glycoprotein, was applied to develop a novel molecular platform. Biocompatible Mn-loaded apolactoferrin Mn2+-Apo-Lf-PEG was first prepared. The first dual-modality imaging NIR-II/MRI nanoprobe (H-dot) was then constructed by linking a NIR-II fluorescent probe (CH1055) to the surface of Mn2+-Apo-Lf-PEG via glutaraldehyde cross linking. Cellular studies showed that the obtained H-dot exhibited low toxicity, excellent stability, biocompatibility, significantly enhanced T1-weighted magnetic resonance imaging (MRI) and superior NIR-II imaging optical properties. The H-dot was subsequently evaluated in subcutaneous HepG2 liver xenografts and subcutaneous/orthotopic U87MG glioblastoma xenografts, revealing its excellent dual imaging properties in small-animal models for the first time, such as high tumor specificity and contrast, good tumor uptake, and accurate tumor delineation. These particular properties of the Mn-loaded apolactoferrin dotmake it a promisingmolecular platform for the development of novel imaging probes and clinical translation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据